In diabetic cardiomyopathy (DCM), the combination of TIL and Syringin significantly reduced the expression of NLRP3, TNF-α, IL-1β, and IL-6 and attenuated myocardial injury [43]. This evidence concerns the gene NLRP3 and diabetic cardiomyopathy.